Dr. Vikas Singh is a highly accomplished Consultant Urological Oncologist in Indore, dedicated to the diagnosis and individualized management of Prostate Cancer. His approach centers on precise risk assessment, leveraging advanced diagnostic tools like MRI-Fusion Biopsy. For curative intervention, he specializes in the definitive surgical technique: Robotic-Assisted Radical Prostatectomy (RARP). This procedure represents the contemporary gold standard for prostate cancer surgery, performed using meticulous nerve-sparing radical prostatectomy methods to optimize urinary control and sexual function restoration. He also skillfully manages low-risk cases through Active Surveillance protocols.
Concentrated expertise in the most sophisticated surgical method for cancer treatment, ensuring superior care standards.
Extensive experience throughout urological oncology, guaranteeing proficiency even in challenging localized or advanced prostate cancer cases.
Utilizing contemporary imaging technology for targeted, highly accurate prostate biopsies, fundamental for appropriate staging.
The initial phase in prostate cancer screening includes a blood test measuring Prostate-Specific Antigen (PSA). We also assess for common prostate cancer symptoms such as urinary difficulties or hematuria. An elevated PSA level warrants further comprehensive investigation.
A Multiparametric MRI (mpMRI) directs the diagnostic pathway. Dr. Singh employs MRI-Fusion Biopsy to precisely target suspicious regions identified on imaging. This is essential for obtaining accurate tissue samples and establishing prostate cancer staging.
The biopsy yields the Gleason Score (Grade Group 1 to 5), which is fundamental to understanding tumor aggressiveness. Comprehending the Gleason score meaning is essential for determining the personalized treatment strategy, whether Active Surveillance for low-risk disease or definitive intervention.
RARP represents the most sophisticated curative surgical approach for significant localized prostate cancer. Dr. Singh utilizes robotic technology for precise nerve-sparing surgery, minimizing impact on adjacent structures. This methodology ensures thorough cancer removal while prioritizing outcomes such as reduced urinary incontinence after prostatectomy and faster restoration of erectile function. Primary Goal: Achieving clear surgical margins, expedited recovery, and maximizing post-surgical continence and potency.
For men with low-risk disease, Active Surveillance (AS) represents the optimal approach, postponing or preventing unnecessary intervention. We also facilitate care for definitive non-surgical alternatives like Radiation Therapy for prostate cancer (External Beam Radiation Therapy – EBRT) or internal Brachytherapy (radioactive seed implants), ensuring all evidence-based treatment options are evaluated based on each patient’s unique profile and preferences. Primary Goal: Preventing overtreatment; delivering personalized guidance on surgical versus radiation therapy alternatives.
Reducing urinary incontinence risk after prostatectomy through careful surgical precision.
Striving to minimize erectile dysfunction risk after prostatectomy using sophisticated nerve-sparing methods.
Minimally invasive Robotic Prostatectomy facilitates swift return to everyday activities.
Precise monitoring for low-risk disease to preserve quality of life and prevent unnecessary treatment.
RARP generally requires a brief hospitalization of 2-3 days. Patients are encouraged to ambulate within hours following surgery to prevent complications. We provide effective pain management, and a urinary catheter remains in place at discharge.
The urinary catheter is typically removed 7-10 days post-surgery. This marks when pelvic floor rehabilitation (Kegel exercises) must begin earnestly. Erectile function restoration is a gradual process, frequently requiring a structured penile rehabilitation program.
Post-RARP surveillance is vital. We monitor your PSA levels every 3-6 months. Successful surgery should yield an undetectable PSA. Consistent monitoring ensures any potential recurrence is identified early and addressed promptly, securing long-term prostate cancer survival.
Schedule a private, confidential consultation with Dr. Singh in Indore.
During early phases, prostate cancer frequently presents no symptoms whatsoever. This underscores why screening is critical. When symptoms emerge, they typically involve urinary flow issues: difficulty initiating/stopping urination, frequent urges (particularly at night), weak or intermittent stream, or occasionally blood in urine or semen. However, these symptoms most commonly result from BPH (non-cancerous prostate enlargement).
Guidelines vary, but for average-risk men, screening typically commences at age 50. If you have risk factors (such as family history of prostate cancer), screening may start earlier, around age 40-45. Always discuss the benefits and limitations of PSA testing with your physician, as it requires shared decision-making.
No, an elevated PSA test result doesn’t automatically signify cancer. Multiple conditions, including common infections (Prostatitis) or non-cancerous enlargement (BPH), can raise PSA. We utilize advanced diagnostics like PSA density and Multiparametric MRI (mpMRI) to evaluate risk before recommending definitive prostate biopsy.
The mpMRI is a specialized, comprehensive prostate scan. It identifies suspicious regions potentially harboring cancer, enabling Dr. Singh to perform highly accurate MRI-Fusion Biopsy. This targeted methodology far surpasses blind biopsies, reducing the risk of missing aggressive cancer and improving prostate cancer staging.
The Gleason Score (now frequently expressed as Grade Group 1 to 5) characterizes how aggressive cancer cells appear microscopically. Grade Group 1 represents the least aggressive form and often qualifies for Active Surveillance. Grade Group 4 or 5 indicates highly aggressive cancer, necessitating immediate definitive treatment like RARP or intensive radiation to achieve optimal outcomes.
Both deliver excellent long-term prostate cancer survival rates. RARP (Robotic-Assisted Radical Prostatectomy) provides the advantage of complete cancer removal with immediate pathological examination. It’s generally the gold standard for healthy men. Radiation is non-invasive but carries different long-term side effects (such as bowel or rectal irritation). The optimal choice depends on your cancer stage, overall health status, and personal preference regarding potential side effects.
Yes. For carefully selected patients with low-volume, non-aggressive cancer (typically Gleason Grade Group 1), Active Surveillance (AS) represents the preferred management approach. This involves regular PSA monitoring, prostate examinations, and follow-up mpMRIs/biopsies. The objective is avoiding unnecessary treatment and associated side effects, intervening only if cancer demonstrates progression signs.
Immediate leakage is common, but with Dr. Singh’s specialized, meticulous nerve-sparing approach, most men regain complete social continence within 3 to 12 months. Continence recovery rates significantly depend on pre-operative function, patient age, and surgeon expertise. Early pelvic floor (Kegel) exercises are essential for accelerating recovery.
Erectile function recovery represents the slowest aspect of recuperation and can require up to 18-24 months. It’s only achievable if the cancer permitted adequate nerve-sparing surgery. Dr. Singh emphasizes early penile rehabilitation (utilizing medication or devices) post-surgery to promote nerve health and maximize the probability of regaining function over time.
The leading center for advanced, compassionate urological care and treatment in Indore, Madhya Pradesh.
